輸液ポンプの世界市場（2025年～2033年）

世界の輸液ポンプの市場規模は、2024年に164億米ドルに達し、2033年には265億米ドルに達すると予測され、予測期間2025年～2033年のCAGRは4.2%で成長する見通しです。

輸液ポンプは、患者に外部から制御された形式で流体を供給する医療機器です。輸液ポンプには基本的に多くの種類があり、いくつかの異なる目的や環境に対応しています。輸液ポンプは、大容量から微量まで非常に幅広い送液設定が可能で、多くの場合、TPN用途や、インスリン、ホルモン、化学療法剤、抗生物質、鎮痛剤などの様々なタイプのIV投薬の両方で使用されます。ベッドサイドで使用する輸液ポンプもあれば、持ち運びや装着が可能な歩行用輸液ポンプもあります。

市場力学：

促進要因と抑制要因

技術進歩の急増

現在、急成長している技術進歩は、世界の輸液ポンプ市場を変化させる重要な役割を担っています。ワイヤレス接続のスマート輸液ポンプやドラッグライブラリなどの進歩やイノベーションは、信頼性と安全性の面でドラッグデリバリーに大きく貢献しています。また、リアルタイムモニタリング、エラー削減システム、遠隔プログラミングなどのハイテク機能と統合されたこれらのソリューションは、集中治療室のようなリスクの高い環境における患者ケアに関する重要な問題に対処しています。

例えば、2024年1月には、薬剤投与を安全に検知する技術を備えた薬剤注入ポンプが世界で初めて開発されました。イ・ドンギュ上級研究員が率いる韓国機械材料研究所は、鎮痛薬輸液ポンプの低流量と気泡の存在を測定するためにカスタマイズされたセンサーモジュールを開発しました。この安全なポンプシステムは、韓国の有名な薬物注入器メーカーであるユニメディックスによる量産を目指して開発されています。この技術は、鎮痛剤の過剰投与による医療事故を防止することを目的としています。

製品リコール

世界の輸液ポンプの市場成長は、製品リコールによって抑制されています。実際、リコールのほとんどは、製造上の欠陥、ソフトウェアの誤動作、または患者への有害な曝露につながる安全上の問題によって引き起こされます。その結果、ブランド名を汚すことになり、市場成長の一過性の停滞を引き起こす可能性があります。リコールは規制当局の監視を強め、適合製品の再設計に数十億米ドルのコストがかかるため、メーカーの収益性に直接影響します。

例えば、2024年10月、Zyno Medicalは、エアインラインソフトウェアアルゴリズムに欠陥があり、1mLの気泡が患者に到達する可能性があるとして、Z800輸液ポンプをリコールしました。この製品は、血管空気塞栓症、頻脈性不整脈、心筋梗塞、脳卒中、発作、死亡を含む重篤な健康被害を引き起こす可能性があります。これまでに2件の負傷者が報告されています。

同様に、2024年4月、InfuTronix, LLCは、バッテリーの不具合、上流の詰まり、システムエラー、製剤の漏れ、流量の高低、ハウジングの損傷などの潜在的な不具合状態によるNimbus輸液ポンプシステムのリコールを2024年6月20日より実施しています。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

• 影響要因
  • 促進要因
    • 技術進歩の急速な増加
  • 抑制要因
    • 製品リコール
  • 機会
  • 影響分析

第5章 産業分析

• ポーターのファイブフォース分析
• サプライチェーン分析
• 価格分析
• 規制分析

第6章 製品タイプ別

• 注射器輸液ポンプ
• ボリューメトリック輸液ポンプ
• 歩行用輸液ポンプ
• インスリン輸液ポンプ
• 患者自己管理鎮痛（PCA）ポンプ
• エラストマーポンプ
• 埋め込み型輸液ポンプ
• 経腸輸液ポンプ

第7章 技術別

• 従来型ポンプ
• スマートポンプ
• ウェアラブルポンプ

第8章 用途別

• 腫瘍学
• 糖尿病管理
• 消化器内科
• 小児科・新生児科
• 鎮痛/疼痛管理
• 心臓病学
• 集中治療室/ICU
• その他

第9章 エンドユーザー別

• 病院
• 外来手術センター（ASC）
• 在宅ケア環境
• 専門クリニック

第10章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • スペイン
  • イタリア
  • その他欧州
• 南米
  • ブラジル
  • アルゼンチン
  • その他南米
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋
• 中東・アフリカ

第11章 競合情勢

• 競合シナリオ
• 市況・シェア分析
• M&A分析

第12章 企業プロファイル

• Medtronic Plc
  • 会社概要
  • 製品ポートフォリオ
    • 製品説明
    • 製品の主要業績評価指標（KPI）
    • 実績および予測の製品販売
    • 製品販売量
  • 財務概要
    • 企業収益
    • 地域別収益シェア
    • 収益予測
  • 主な発展
    • 合併と買収
    • 主な製品開発活動
    • 規制当局の承認等
  • SWOT分析
• Baxter International Inc
• B. Braun Melsungen AG
• Fresenius Kabi AG
• ICU Medical, Inc
• Terumo Corporation
• Micrel Medical Devices SA
• Moog Inc
• Mindray Medical International Ltd
• BD（Becton, Dickinson and Company）
• KORU Medical Systems
  • パイプライン製品の説明
  • 製品の主要業績評価指標（KPI）
  • 主な活動
  • 市場参入のタイムライン
  • 製品普及率
  • 売上推定と予測
• Tandem Diabetes Care, Inc
• Eitan Medical
• Q-Core Medical Ltd

第12章 付録

The global infusion pumps market reached US$ 16.4 billion in 2024 and is expected to reach US$ 26.5 billion by 2033, growing at a CAGR of 4.2% during the forecast period 2025-2033.

Infusion pumps are the medical devices that's delivers a patient to flow fluids externally and in a controlled format. There are basically many different types of infusion pumps which serve several different purposes and environments. An infusion pump can have a very wide range of delivery settings from large volume down to as low as micro delivery, and often are used in both TPN applications and various types of I.V. medications - insulin and hormones, chemotherapeutic agents, antibiotics, analgesics, etc. Some infusion pumps present themselves for use at the bedside; others are designed as ambulatory infusion pumps for portability or wearability.

Market Dynamics: Drivers & Restraints

Rapid Increase of Technological Advancements

At present, fast-growing technological advancement is taking an essential part in transforming the infusion pumps market worldwide. The advancements and innovations such as smart infusion pumps with wireless connections and drug libraries have contributed a lot toward drug delivery in terms of reliability and safety. Also integrated with high-tech features such as real-time monitoring, error reduction systems, and remote programming, these solutions are addressing critical issues about patient care in high-risk settings such as intensive care units.

For instance, in January 2024, a drug infusion pump with a technology for safely detecting medication administration has been developed for the first time globally. The Korea Institute of Machinery and Materials, led by Senior Researcher Dong-kyu Lee, developed customized sensor modules to measure the low flow rate of analgesic drug infusion pumps and the presence of bubbles. The safe pump system is being developed for mass production by Unimedics, a renowned manufacturer of medication injectors in Korea. This technology aims to prevent medical accidents caused by excessive analgesic drug administration.

Product Recalls

The market growth of global infusion pumps are hindered by product recalls. In fact, most recalls are triggered by manufacturing faults, software malfunctioning, or safety issues that lead to adverse patient exposure. This results into tarnishing brand names and is capable of causing a very transient stall in market growth. Recalls provoke greater scrutiny from regulators and cost Billions of dollars to be re-engineered into compliant products which directly affect the profitability of manufacturers.

For instance, in October 2024, Zyno Medical is recalled select Z800 infusion pumps due to a defect in the air-in-line software algorithm, potentially allowing a 1 mL air bubble to pass to a patient. The product may cause serious adverse health consequences, including vascular air embolism, tachyarrhythmia, myocardial infarction, stroke, seizure, and death. There have been two reported injuries.

Similarly, in April 2024, InfuTronix, LLC is recalled Nimbus infusion pump systems due to potential failure modes such as battery failure, upstream blockage, system errors, drug product leakage, high or low flow rate, or damaged housing, effective June 20, 2024.

Segment Analysis

The global infusion pumps market is segmented based on product type, technology, application, end user and region.

Product Type:

Syringe infusion pumps segment is expected to dominate the Infusion Pumps market share

The syringe infusion pumps segment holds a major portion of the infusion pumps market share and is expected to continue to hold a significant portion of the infusion pumps market share during the forecast period.

Syringe infusion pumps are a vital component of the global infusion pumps market, providing precise and controlled delivery of small volumes of fluids and medications. They are particularly useful in critical care settings like neonatal and pediatric care, where accuracy is crucial due to patients' small size and sensitivity to dosage errors. They are also crucial for administering high-potency drugs like chemotherapy agents, anesthetics, and pain management medications. Their compact design and ability to deliver medications at low flow rates make them ideal for hospital and ambulatory care. Advancements in syringe pump technology, such as dose error reduction systems and wireless connectivity, have enhanced their efficiency and safety.

For instance, in April 2024, Baxter International has received FDA 510(k) clearance for its Novum IQ large volume infusion pump (LVP) with Dose IQ Safety Software. This addition to the Novum IQ Infusion Platform, which includes Baxter's syringe infusion pump (SYR) with Dose IQ Safety Software, allows clinicians to use a single, integrated system across various patient care settings. Baxter's commitment to innovation in infusion therapy is demonstrated by offering the Novum IQ LVP in the U.S.

End User:-

Hospitals segment is the fastest-growing segment in Infusion Pumps market share

The hospitals segment is the fastest-growing segment in the infusion pumps market share and is expected to hold the market share over the forecast period.

Hospitals are the largest end-users of infusion pumps globally, providing precise and controlled dosages of fluids, medications, and nutrients to patients across various departments. The increasing incidence of chronic diseases, surgical procedures, and critical care requirements has increased demand for infusion pumps.

For instance, in April 2024, Mackenzie Health has introduced BD Alaris EMR Interoperability, a two-way information flow technology that enables two-way communication between an IV medication pump and a patient's electronic medical record. This eliminates the need for healthcare professionals to manually program pumps and send infusion safety information back to Epic EMR, thereby reducing administration errors and providing accurate infusion records.

Moreover, in April 2023, Nathan Littauer Hospital & Nursing Home has opted for B Braun Medical Inc.'s Infusomat Space 2nd Generation Large Volume Pumps due to their efficiency and accuracy, ensuring safer patient care for the hospital's patients.

Geographical Analysis

North America is expected to hold a significant position in the Infusion Pumps market share

North America holds a substantial position in the infusion pumps market and is expected to hold most of the market share due to its advanced healthcare infrastructure, FDA approvals, high healthcare expenditure, and early adoption of innovative medical technologies. The region's high prevalence of chronic diseases like diabetes, cancer, and cardiovascular disorders drives demand for infusion pumps. Major market players like Medtronic, Baxter, and B. Braun ensure continuous innovation and availability of cutting-edge products. The strong regulatory framework and emphasis on patient safety drive the adoption of smart infusion pumps with integrated error-reduction systems.

For instance, in May 2024, Moog Inc has secured 510(k) clearance from the United States Food and Drug Administration (FDA) for the CURLIN 8000 Ambulatory Infusion System in the Industrial segment. This high-end infusion platform has been designed specifically for use in home infusion facilities.

Moreover, in July 2023, Becton, Dickinson and Company, or BD, is a global leader in medical technology that announced that the BD Alaris update, the latest version of the BD Alaris Infusion System, has been granted 510(k) clearance by the United States Food and Drug Administration (FDA) to remediate and then return to full commercial operations for the most comprehensive use-infusion system in the United States.

Europe is growing at the fastest pace in the Infusion Pumps market

Europe holds the fastest pace in the infusion pumps market and is expected to hold most of the market share due to aging population and chronic diseases. Countries like Germany, France, and the UK lead the market due to their advanced healthcare systems. The focus on personalized medicine and homecare has increased demand for portable infusion pumps. The European Union's focus on reducing hospital stays and promoting outpatient care has fueled the adoption of infusion technology in ambulatory settings. Government funding, collaborations, and competitive pricing from local and international manufacturers drive market growth.

For instance, in May 2023, Fresenius Kabi announced that it has joined Premier, Inc. in a Breakthrough Technology group purchasing agreement. Under the agreement, which comes into effect May 1, 2023, Premier members may opt to take advantage of special pricing and terms negotiated in advance by Premier for the Ivenix Infusion System from Fresenius Kabi.

Competitive Landscape

The major global players in the infusion pumps market include Medtronic plc, Baxter International Inc, B. Braun Melsungen AG, Fresenius Kabi AG, ICU Medical, Inc, Terumo Corporation, Micrel Medical Devices SA, Moog Inc, Mindray Medical International, Ltd, BD (Becton, Dickinson and Company) and among others.

Key Developments

• In June 2023, B. Braun Medical Inc. has launched DoseTrac Enterprise Infusion Management Software, a next-generation infusion management software. The software offers real-time views and retrospective reporting features to help organizations understand their infusion pump fleet and associated data. It can connect up to 40,000 pumps at an unlimited number of facilities with just one application.
• In February 2023, Mindray has introduced its BeneFusion i Series and u Series infusion systems, offering high precision, adaptive customization, and simplicity for medication safety in various clinical settings, available in select countries and regions.

Why Purchase the Report?

• Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
• Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
• Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
• Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
• Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
• Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
• Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
• Post-market Surveillance: Uses post-market data to enhance product safety and access.
• Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global infusion pumps market report delivers a detailed analysis with 68+ key tables, more than 72 visually impactful figures, and 236 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

• Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Application & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
• Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Product Type
• 3.2. Snippet by Technology
• 3.3. Snippet by Application
• 3.4. Snippet by End User
• 3.5. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Rapid Increase of Technological Advancements
  • 4.1.2. Restraints
    • 4.1.2.1. Product Recalls
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Force Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis

6. By Product Type

• 6.1. Introduction
  • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 6.1.2. Market Attractiveness Index, By Product Type
• 6.2. Syringe Infusion Pumps*
  • 6.2.1. Introduction
  • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 6.3. Volumetric Infusion Pumps
• 6.4. Ambulatory Infusion Pumps
• 6.5. Insulin Infusion Pumps
• 6.6. Patient-Controlled Analgesia (PCA) Pumps
• 6.7. Elastomeric Pumps
• 6.8. Implantable Infusion Pumps
• 6.9. Enteral Infusion Pumps

7. By Technology

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 7.1.2. Market Attractiveness Index, By Technology
• 7.2. Traditional Pumps*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Smart Pumps
• 7.4. Wearable Pumps

8. By Application

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 8.1.2. Market Attractiveness Index, By Application
• 8.2. Oncology*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Diabetes Management
• 8.4. Gastroenterology
• 8.5. Pediatrics/Neonatology
• 8.6. Analgesia/Pain Management
• 8.7. Cardiology
• 8.8. Critical Care/ICU
• 8.9. Others

9. By End User

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 9.1.2. Market Attractiveness Index, By End User
• 9.2. Hospitals*
  • 9.2.1. Introduction
  • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 9.3. Ambulatory Surgical Centers (ASCs)
• 9.4. Homecare Settings
• 9.5. Specialty Clinics

10. By Region

• 10.1. Introduction
  • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 10.1.2. Market Attractiveness Index, By Region
• 10.2. North America
  • 10.2.1. Introduction
  • 10.2.2. Key Region-Specific Dynamics
  • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.2.7.1. U.S.
    • 10.2.7.2. Canada
    • 10.2.7.3. Mexico
• 10.3. Europe
  • 10.3.1. Introduction
  • 10.3.2. Key Region-Specific Dynamics
  • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.3.7.1. Germany
    • 10.3.7.2. U.K.
    • 10.3.7.3. France
    • 10.3.7.4. Spain
    • 10.3.7.5. Italy
    • 10.3.7.6. Rest of Europe
• 10.4. South America
  • 10.4.1. Introduction
  • 10.4.2. Key Region-Specific Dynamics
  • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.4.7.1. Brazil
    • 10.4.7.2. Argentina
    • 10.4.7.3. Rest of South America
• 10.5. Asia-Pacific
  • 10.5.1. Introduction
  • 10.5.2. Key Region-Specific Dynamics
  • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.5.7.1. China
    • 10.5.7.2. India
    • 10.5.7.3. Japan
    • 10.5.7.4. South Korea
    • 10.5.7.5. Rest of Asia-Pacific
• 10.6. Middle East and Africa
  • 10.6.1. Introduction
  • 10.6.2. Key Region-Specific Dynamics
  • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

• 11.1. Competitive Scenario
• 11.2. Market Positioning/Share Analysis
• 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

Key Market Players

• 12.1. Medtronic Plc*
  • 12.1.1. Company Overview
  • 12.1.2. Product Portfolio
    • 12.1.2.1. Product Description
    • 12.1.2.2. Product Key Performance Indicators (KPIs)
    • 12.1.2.3. Historic and Forecasted Product Sales
    • 12.1.2.4. Product Sales Volume
  • 12.1.3. Financial Overview
    • 12.1.3.1. Company Revenue's
    • 12.1.3.2. Geographical Revenue Shares
    • 12.1.3.3. Revenue Forecasts
  • 12.1.4. Key Developments
    • 12.1.4.1. Mergers & Acquisitions
    • 12.1.4.2. Key Product Development Activities
    • 12.1.4.3. Regulatory Approvals etc.
  • 12.1.5. SWOT Analysis
• 12.2. Baxter International Inc
• 12.3. B. Braun Melsungen AG
• 12.4. Fresenius Kabi AG
• 12.5. ICU Medical, Inc
• 12.6. Terumo Corporation
• 12.7. Micrel Medical Devices SA
• 12.8. Moog Inc
• 12.9. Mindray Medical International Ltd
• 12.10. BD (Becton, Dickinson and Company)
• Similar data will be provided for each market player.

Emerging Market Players

• 12.11. KORU Medical Systems*
  • 12.11.1. Pipeline Products Description
  • 12.11.2. Product Key Performance Indicators (KPIs)
  • 12.11.3. Key Activities
  • 12.11.4. Market Entry Timelines
  • 12.11.5. Product Penetration Rate
  • 12.11.6. Sales Estimation and Projections
• 12.12. Tandem Diabetes Care, Inc
• 12.13. Eitan Medical
• 12.14. Q-Core Medical Ltd
• Similar data will be provided for each market player.

LIST NOT EXHAUSTIVE

12. Appendix

• 12.1 About Us and Services
• 12.2 Contact Us